Claim analyzed

Health

“Red-light therapy causes dark spots on the skin.”

Mixed
6/10

Dark spots are a possible but conditional adverse effect of red-light therapy. The risk appears greater in darker skin tones and with higher exposures, while controlled treatment may instead improve melasma or other pigmentation. Presenting discoloration as a general outcome materially overstates the evidence.

Caveats

  • Risk varies with skin tone, wavelength, dose, treatment duration, and device quality.
  • Red-light therapy may reduce rather than worsen pigmentation under controlled protocols.
  • Individual adverse-event reports cannot establish how commonly treatment causes discoloration.

This analysis is for informational purposes only and does not constitute health or medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before making health-related decisions.

Sources

Sources used in the analysis

#1
aad.org 2024-09-13 | Is red light therapy right for your skin?

Research shows that people who have darker skin tones are more sensitive to visible light, such as red light, than people with lighter skin tones. This increased sensitivity can lead to hyperpigmentation, and the resulting dark spots can be more intense and long-lasting than dark spots caused by invisible light, such as sunlight.

#2
jcadonline.com 2018-04-01 | Dual Effect of Photobiomodulation on Melasma

Using cultured human melanocytes, Kim et al24 showed that NIR LED wavelengths (via PBM) effectively inhibit melanin biosynthesis and its molecular mechanisms, underlying its effects on tyrosinase, tyrosinase-related protein 1, and microphthalmia-associated transcription factor expression with an intracellular signaling pathway. … This pilot study demonstrates that dermal melasma might be improved without tissue damage by using pulsed PBM photons.

#3
doi.org 2022-12-07 | 590 nm LED Irradiation Improved Erythema through Inhibiting Angiogenesis of Human Microvascular Endothelial Cells and Ameliorated Pigmentation in Melasma

In our study, we observed a significant improvement of erythema, pigmentation and skin texture in melasma patients after 590 nm LED treatment.

#4
pmc.ncbi.nlm.nih.gov 2015-06-01 | Light-emitting Diodes: A Brief Review and Clinical Experience - PMC

Review of the literature revealed that differing wavelengths of light-emitting diode devices have many beneficial effects, including wound healing, acne treatment, sunburn prevention, phototherapy for facial rhytides, and skin rejuvenation. … Generally, minimal to no side effects were experienced. One patient reported post-treatment erythema that lasted 24 hours.

#5
pmc.ncbi.nlm.nih.gov 2021-05-04 | Light emitting diode-red light for reduction of post-surgical scarring: Results from a dose-ranging, split-face, randomized controlled trial - PMC

In two phase I, dose escalation, randomized controlled trials (Safety Trial Assessing Red-light on Skin [STARS 1 and STARS 2], n=115), we evaluated the safety and tolerability of LED-RL administered at fluences up to 640 J/cm2 on normal skin.38 Adverse events (AEs) included treatment-site erythema, hyperpigmentation, and blistering, all of which were mild and resolved without permanent sequelae.38

#6
health.harvard.edu 2025-10-21 | Red light therapy for skin care

While it's not a miracle fix for skin issues, the AAD says that research suggests red light therapy can help - reduce fine lines and wrinkles - lighten dark spots … Check with your dermatologist beforehand if you have darker skin, since you may be more sensitive to visible light like red light, which can lead to dark spots.

#7
clinicaltrials.gov Evaluation of the Efficacy and Tolerance of a Light Therapy Mask on Mild to Moderate Brown Spots and Moderate to Severe Facial Wrinkles

This research study will test how well a light therapy mask works for women with mild to moderate hyperpigmentation (brown spots) and moderate to severe facial wrinkles, as compared to a "sham" or inactive investigational light therapy mask.

#8
onlinelibrary.wiley.com 2023-11-28 | Photobiomodulation for melasma treatment: Integrative review and state of the art

Clinical studies, in agreement with in vitro experiments and animal models, suggest that PBM effectively reduces melasma-associated hyperpigmentation. … Specific wavelengths (red: 630 nm; amber: 585 and 590 nm; infrared: 830 and 850 nm) at radiant exposures between 1 and 20 J/cm2 exert modulatory effects on tyrosinase activity, gene expression, and protein synthesis of melanocytic pathway components, and thus significantly reduce the melanin content.

#9
mdpi.com 2024-04-19 | Unlocking the Power of Light on the Skin: A Comprehensive Review on Photobiomodulation

Visible light (400–700 nm) may produce non-transient hyperpigmentation in skin of color. … A clinical trial demonstrated that skin of color presents higher photosensitivity to visible light, showing differences of up to 50% in the maximum tolerated dose of LED red light when compared to lighter skin types [220]. … In this study, the authors defined the mentioned maximum tolerated dose as one that did not produce an adverse effect such as non-transient erythema or hyperpigmentation.

#10
journals.viamedica.pl 2026-04-28 | Light-emitting diode photobiomodulation in dermatology: From professional systems to consumer devices — mechanisms, efficacy and safety | Koperdowska | Forum Dermatologicum

A major concern in melasma management is the well-documented sensitivity of melanocytes to visible light, particularly within the 400–700 nm range. Visible light can activate melanogenesis independently of ultraviolet radiation. … A pivotal study by Mahmoud et al. [12] demonstrated that exposure to visible light induces darker and more persistent pigmentation in Fitzpatrick phototypes IV–VI compared with UVA1, with pigment persisting for up to 14 days.

#11
link.springer.com 2024-06-19 | An Update on New and Existing Treatments for the Management of Melasma | American Journal of Clinical Dermatology | Springer Nature Link

Light emitting diode (LED) use for melasma, particularly with red or infrared light, has low evidence but may contribute to melasma treatment [146,147, 148]. … Red light has been used to both increase and decrease skin pigmentation, depending on the indication [149].

#12
my.clevelandclinic.org 2021-12-01 | Red Light Therapy: Benefits, Side Effects & Uses

Red light therapy is promoted as a treatment for some common skin conditions, including to: - Improve wound healing. - Reduce stretch marks. - Reduce wrinkles, fine lines and age spots.

#13
odermatol.com 2025-09-29 | 2025e.32.LED_photobiomodulation - Our Dermatology Online

In contrast, red light (typically in the range of 620–750 nm) does not activate the same melanogenic pathways and, in some cases, has been investigated for its potential to reduce hyperpigmentation by modulating inflammation and oxidative stress.

#14
bmjopen.bmj.com Efficacy of phototherapy to treat facial ageing when using a red versus an amber LED: a protocol for a randomised controlled trial | BMJ Open

Many in vitro, in vivo and clinical studies have demonstrated the anti-inflammatory, repair, skin rejuvenation and healing effects that are promoted by red light.

#15
accessdata.fda.gov 2024-10-28 | MAUDE Adverse Event Report: NIRA INNOVATIONS INC. NIRA ANTI-AGING LASER DEVICE; LIGHT BASED OVER THE COUNTER WRINKLE REDUCTION

After a few weeks of use under my eyes.I noticed that had a tremendous fat loss under my eyes and my eyes looked bruised.After two years the discoloration did not go away.

#16
pmc.ncbi.nlm.nih.gov 2023-06-30 | Reverse skin aging signs by red light photobiomodulation - PMC

Lucibel's research allowed to choose only the red light rather than the combination of red light and infrared light, to minimize the risks for a home device. Indeed, the risk of pigmentation especially on dark skins.

#17
clinicaltrials.gov Efficacy of Red Light in the Treatment of Pigmentary Disorders

This is a prospective, double-blind, split-body, randomized controlled trial assessing the efficacy of low level laser therapy with red light for pigmentary disorders such as, melasma, lichen planus pigmentosus and vitiligo.

#18
accessdata.fda.gov TPLC - Total Product Life Cycle

The device is intended to emit energy in the red and blue region of the spectrum, specifically indicated to treat mild to moderate acne vulgaris. … Skin Discoloration

#19
clinicaltrials.gov 2013-02-11 | Efficacy of Red Light in Vitiligo

Visible red light has been shown to stimulates melanocyte migration and proliferation resulting in repigmentation of vitiligo patches.

#20
link.springer.com 2025-07-25 | Photobiomodulation and Photodynamic Therapy Using Red LED Light in Dermatology: A Narrative Review | Bratislava Medical Journal | Springer Nature Link

Overall, the treatment was effective and well-tolerated with minimal long-term side effects.

#21
fda.innolitics.com 2024-11-27 | LED Light Therapy Machine (G1, G3, G4, G6) (K242638) — FDA 510(k) | Innolitics

Red light: Treatment of full-face wrinkles.

#22
uptodate.com 2024-04-29 | Laser and light therapy for cutaneous hyperpigmentation - UpToDate

Lasers and light-based modalities are used to treat a wide variety of disorders characterized by the presence of cutaneous hyperpigmentation via photothermal, photomechanical, and ablative mechanisms.

#23
cosmoderma.org 2025-11-19 | Photonic frontiers in melasma: Navigating layers, risks, and ...

Recent professional opinions warn against the uncontrolled application of red and blue LED mask devices in place of melasma-prone individuals, as the stimulation of melanocytes with a subsequent increase of heat is possible.

#24
webmd.com 2019-10-18 | Red Light Therapy: Effectiveness, Treatment, and Risks

One early-stage clinical trial found that at high levels, red LED lights such as those used in red light therapy can cause blistering and redness on the skin.

#25
pmc.ncbi.nlm.nih.gov Safety of light emitting diode-red light on human skin - PMC
#26
pmc.ncbi.nlm.nih.gov Photobiomodulation for Skin Pigmentation Disorders - PMC
#27
pmc.ncbi.nlm.nih.gov Unlocking the Power of Light on the Skin - PMC - NIH
#28
ncbi.nlm.nih.gov Checking your browser - reCAPTCHA
#29
ncbi.nlm.nih.gov Checking your browser - reCAPTCHA
#30
journals.viamedica.pl Light-emitting diode photobiomodulation in dermatology:
Full Analysis

Debate

Two AI advocates debated this claim using the research gathered.

Argument for

P
Proponent Argues TRUE

Research from authoritative dermatological sources confirms that red light therapy can cause dark spots, particularly in individuals with darker skin tones, as visible light induces non-transient hyperpigmentation and activates melanogenesis (Source 1, Source 9, Source 10). Furthermore, clinical trials have documented hyperpigmentation as an adverse event following red light exposure, demonstrating that the therapy carries a clear risk of causing persistent dark spots (Source 5, Source 16).

O
Opponent Rebuttal

The Proponent overgeneralizes Source 1 (aad.org), Source 9 (mdpi.com), and Source 10 (journals.viamedica.pl) on visible-light sensitivity in darker skin into a causal claim that red-light therapy causes dark spots, while ignoring that those passages address broad visible light rather than therapeutic red PBM parameters shown to inhibit melanin and improve pigmentation in Source 2 (jcadonline.com), Source 3 (doi.org), Source 6 (health.harvard.edu), Source 8 (onlinelibrary.wiley.com), and Source 13 (odermatol.com). The Proponent further misreads Source 5 (pmc.ncbi.nlm.nih.gov) and Source 16 (pmc.ncbi.nlm.nih.gov), which describe only rare, mild, dose-dependent, and resolving hyperpigmentation or risk-minimization choices, not evidence that red-light therapy generally causes persistent dark spots.

Argument against

O
Opponent Argues FALSE

The claim is false because multiple high-quality sources establish that red-light therapy and photobiomodulation reduce rather than cause dark spots, with Source 6 (health.harvard.edu) stating it can lighten dark spots, Source 8 (onlinelibrary.wiley.com) concluding PBM significantly reduces melanin and melasma hyperpigmentation, Source 2 (jcadonline.com) and Source 3 (doi.org) showing inhibition of melanin biosynthesis and improved pigmentation, and Source 13 (odermatol.com) noting red light does not activate melanogenic pathways. Any reported hyperpigmentation is rare, mild, dose-dependent, and transient in specific darker skin types rather than a general causal effect, as Source 5 (pmc.ncbi.nlm.nih.gov) documents resolved mild events and Source 4 (pmc.ncbi.nlm.nih.gov) reports minimal to no side effects overall.

P
Proponent Rebuttal

The Opponent cherry-picks Source 6 (health.harvard.edu) to argue the therapy lightens pigmentation, conveniently omitting the same source's explicit warning that red light can actually cause dark spots in individuals with darker skin tones. Furthermore, the Opponent falsely characterizes these adverse effects as transient, directly contradicting Source 9 (mdpi.com) and Source 10 (journals.viamedica.pl), which confirm that visible light induces non-transient, persistent hyperpigmentation in skin of color.


Panel Review

3 specialized AI experts evaluated the evidence and arguments.

Reviewer 1 — The Logic Examiner

Focus: Inferential Soundness & Fallacies
Mostly False
3/10

The claim as a bare universal causal statement ('red-light therapy causes dark spots') is contradicted by the bulk of the evidence, which shows red/PBM light is used therapeutically to reduce hyperpigmentation and melasma (Sources 2, 3, 6, 8, 13) via inhibition of melanogenesis, while the risk of induced hyperpigmentation is consistently qualified as occurring mainly in darker skin tones, at high fluences, and often mild/transient (Sources 1, 5, 9, 10, 16); the Proponent's inference commits a hasty generalization by extrapolating a conditional, dose- and skin-type-dependent adverse effect into an unqualified general causal claim, while the Opponent's rebuttal correctly identifies this overgeneralization but itself risks understating that some sources (9, 10) do document non-transient effects in specific populations. The correct logical reading is that the evidence supports a nuanced, conditional truth (risk in darker skin at high doses) rather than the sweeping claim as stated, making the claim as worded mostly false, though not entirely without basis.

Logical fallacies

The Proponent commits a hasty generalization by inferring a universal causal claim from evidence that documents a conditional, skin-type- and dose-dependent adverse effect.The Proponent's rebuttal conflates cherry-picked qualifiers, treating the darker-skin caveat as if it establishes general causation for all users.The Opponent's argument partially commits a false dichotomy by framing the evidence as either purely therapeutic or purely causal, understating that both effects are documented under different conditions.
Confidence: 8/10

Reviewer 2 — The Source Auditor

Focus: Source Reliability & Independence
Mostly True
8/10

The American Academy of Dermatology (Source 1) directly warns that red light can lead to hyperpigmentation in darker skin tones, and independent clinical and review evidence (Sources 5 and 9) documents hyperpigmentation as an adverse effect or a non-transient visible-light response, although studies of controlled photobiomodulation also report improvement in melasma (Sources 2, 3, and 8). Therefore, trustworthy evidence supports that red-light therapy can cause dark spots in susceptible people or at certain exposures, but it is not an inevitable or universal outcome.

Weakest sources

Source 15 is a single self-reported FDA adverse-event entry and cannot by itself establish that the device caused the reported discoloration.
Confidence: 8/10

Reviewer 3 — The Precision Analyst

Focus: Claim Precision & Quantitative Accuracy
Mixed
5/10

The claim uses an unqualified causal verb, implying that red-light therapy universally causes dark spots, whereas the evidence shows this is a specific risk primarily for individuals with darker skin tones or at high doses (Sources 1, 6, 9). Furthermore, the claim omits that red-light therapy is also widely used to treat and lighten dark spots (Sources 6, 8, 12), making the blanket statement imprecise.

Precision issues

The claim lacks scope qualifiers, overgeneralizing a risk specific to darker skin tones or high doses to all users.The unqualified causal phrasing 'causes' ignores evidence that the therapy is also used to reduce or treat dark spots.
Confidence: 9/10

Panel summary

See the full panel summary

Create a free account to read the complete analysis.

Sign up free
The claim is
Mixed
6/10
Confidence: 8/10 Spread: 5 pts

Only you will see this note.

Embed this verification

Every embed carries schema.org ClaimReview microdata — recognized by Google and AI crawlers.

Mixed · Lenz Score 6/10 Lenz
“Red-light therapy causes dark spots on the skin.”
30 sources · 3-panel audit
See full report on Lenz →